H. Schoenfeld

Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation

D. Banner, R. Gentz, A. D'arcy, 1993, Cell.

Separation of Fast from Slow Anabolism by Site-specific PEGylation of Insulin-like Growth Factor I (IGF-I)*

F. Metzger, A. Hoeflich, H. Schoenfeld, 2011, The Journal of Biological Chemistry.

A new ELISA test for HIV antibodies using a bacterially produced viral env gene product

H. Schoenfeld, J. Mous, D. Stüber, 2004, Medical Microbiology and Immunology.

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

H. Schoenfeld, H. Loetscher, W. Lesslauer, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum

P. Caspers, H. Schoenfeld, H. Matile, 1991, Infection and immunity.

Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors.

M. Zulauf, A. Lustig, H. Schoenfeld, 1991, The Journal of biological chemistry.

Two Distinct Tumor Necrosis Factor Receptors in Health and Disease

D. Banner, R. Gentz, H. Schoenfeld, 1993 .

Separation of Fast from Slow Anabolism by Site-specific PEGylation of Insulin-like Growth Factor I (IGF-I)*

F. Metzger, A. Hoeflich, H. Schoenfeld, 2011, The Journal of Biological Chemistry.